 | Cassava Sciences, Inc. | |||
| NCM : SAVA || Location: United States | ||||
$21.27+0.24 (+1.14%) |
0.63 M | 20.76 - 21.59 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 11.789 M |
| March 15, 2024 | 11.959 M |
| Feb. 29, 2024 | 11.318 M |
| Feb. 15, 2024 | 11.762 M |
| Jan. 31, 2024 | 12.183 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.53 | -0.50 | 5.73% |
| 09/30/2023 | -0.79 | -0.61 | 22.83% |
| 06/30/2023 | -0.60 | -0.63 | -4.69% |
| 03/31/2023 | -0.57 | -0.58 | -2.46% |
| 12/31/2022 | -0.57 | -0.47 | 17.72% |
Recent Dividends
| Div Date | Div Amount |
|---|---|
| 12/13/2012 | 0.75 |
| 12/13/2010 | 2.00 |
SAVA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 43.246M | Shares Float | 40.196M |
| Short Float | 11.789M | Market Cap | 909.46M |
| Institution ownership | 32.70% | Insider ownership | 7.171% |
| Earnings Date | 04/29/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.32 | Forward EPS | -0.47 |